Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
S., Pisarev, V
Our team will monitor your progress and adjust any necessary components during this time
Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy
PubChem Compound Summary for CID 132558700, CID 132558700 PubChem, National Center for Biotechnology Information
Not FDA-approved sounds alarming, but it does not mean illegal and it does not automatically mean unsafe
US$ 21.70
US$ 26.43
US$ 29.39
US$ 20.99
US$ 25.70
US$ 21.93
US$ 24.11
US$ 20.82
US$ 21.56
US$ 28.42
